LIMNW

Liminatus Pharma Inc. Warrants (LIMNW)

Stock · NASDAQ · Health Care

$0.0435as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Liminatus Pharma Inc. Warrants Competitors

Chosen by industry and closest market cap.

  • LIMNW
    Liminatus Pharma Inc. Warrants
    $0.0435
    ▼ 35.65%
    Market cap $4.45MP/E
  • PHGE
    BiomX Inc. COmmon Stock
    $0.138
    ▲ 4.55%
    Market cap $3.95MP/E
    $0.1192$12.29
  • VIVS
    VivoSim Labs Inc. Common Stock
    $0.29
    ▲ 0.00%
    Market cap $5.53MP/E
    $0.2625$5.3
  • AIM
    AIM ImmunoTech Inc. Common Stock
    $0.2558
    ▲ 2.32%
    Market cap $7.51MP/E
    $0.1901$2.89
  • SCNI
    Scinai Immunotherapeutics Ltd. American Depositary Shares
    $2.53
    ▼ 5.60%
    Market cap $1.30MP/E 0.14
    $2.15$16.8
  • BTTC
    Black Titan Corporation Ordinary Shares
    $0.4334
    ▼ 7.98%
    Market cap $1.02MP/E
  • CRIS
    Curis Inc. Common Stock
    $1.49
    ▲ 2.76%
    Market cap $8.59MP/E
    $1.4$39

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
1.66M
Total value held
$74.4K
Institutional holders
22
Top holders this quarter
  • Unknown319.5K
  • Unknown268.2K
  • Unknown233.8K
  • Unknown125.0K
  • Unknown122.7K
  • Unknown111.7K
  • Unknown83.4K
  • Unknown70.6K
  • Unknown50.0K
  • Unknown47.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.